c

Immunotherapy (Acarizax) for dust mite allergy and allergic rhinitis

20th March 2025 by Dr Louise Hudman

Immunotherapy (Acarizax) for dust mite allergy and allergic rhinitis

NICE has approved the use of a new immunotherapy for treating house dust mite-related allergic rhinitis.

This guidance was published in March 2025.

What is the treatment?

It is the very snappily named ’12 SQ-HDM SLIT’. Its trade name is ACARIZAX.

  • 12 SQ stands for 12 µg standardised quantity
  • HDM stands for House Dust Mite.
  • SLIT stands for sublingual immunotherapy tablets.

Upgrade

Booking fees £15/session.

Find out more

Login

Already a member? Login to view this content.

Login